CRY1 fuels resistance to T cell-based immunotherapy in NANOGhigh cancers
Tae Woo Kim(Korea University), Kwon‐Ho Song(Daegu Catholic University)
Cited by 1
Related Papers
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
|Nature Communications|2020|98
Enhancing dendritic cell vaccine potency by combining a <i>BAK/BAX</i> siRNA‐mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments
|International Journal of Cancer|2007|39
TRPV1 inhibition sensitizes tumors to PD-1 blockade by reversing resistance to CTL-mediated killing
|Scientific Reports|2025|2
The E2F1-HMGCR axis promotes ferroptosis resistance in immune refractory tumor cells
|Nature Communications|2025|1